Gabapentin Tablet, Coated
Product Images NDC 69367-346

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 69367-346). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Westminster Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Gabapenin 01)

Chemical structure diagram of gabapentin, showing its cyclohexane ring bonded to aminomethyl (CH2NH2) and carboxymethyl (CH2CO2H) groups.*

FDA Label Image

Figure 1 (Gabapenin 02)

Line graph depicting mean pain scores over an 8-week period comparing placebo and Gabapentin at a dose of 3,600 mg/day. The timeline includes a 4-week dose titration period followed by a 4-week fixed dose period, with pain scores decreasing for Gabapentin while remaining relatively stable for placebo.*

FDA Label Image

Figure 2 (Gabapenin 03)

A line graph depicting mean pain scores over a total of 7 weeks, including a 3-week dose titration period and a 4-week fixed dose period. The graph compares three groups: placebo, gabapentin 1800 mg/day, and gabapentin 2400 mg/day, showing changes in mean pain score from baseline through week 7.*

FDA Label Image

Figure 3 (Gabapenin 04)

A bar chart comparing percentages between placebo (PBO) and gabapentin (GBP) groups in two studies. The chart shows higher percentages in GBP groups at dosages of 1,800 mg, 2,400 mg, and a noted 3,600 mg, with statistical significance marked as p < 0.01 and p < 0.001.*

FDA Label Image

Figure 4 (Gabapenin 05)

A scatter plot comparing differences in percentage across three studies (labeled Study a, Study b, Study c) at different daily doses of a medication ranging from 600 mg to 1800 mg. The vertical axis represents percentage difference, while the horizontal axis shows daily dose in milligrams. Each study is represented by distinct colored squares on the graph.*

FDA Label Image

Principal Display Panel (600 mg Tablet Bottle Label)

Gabapentin Tablets USP 600 mg coated tablets label displaying dosage strength and quantity of 500 tablets. The label includes storage instructions and manufacturer information showing Westminster Pharmaceuticals, LLC as labeler and CSPC Ouvi Pharmaceutical Co., Ltd as manufacturer. The label design features barcodes, branding, and control instructions for prescription use only.*

FDA Label Image

Principal Display Panel (800 mg Tablet Bottle Label)

Gabapentin Tablets, USP 800 mg coated tablets in a 500 count package. Label shows the NDC 69367-347-05, manufactured by CSPC OuYi Pharmaceutical Co., Ltd and for Westminster Pharmaceuticals, LLC. It includes storage instructions and advises pharmacists to dispense the Medication Guide separately.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.